Boeing Reaches Tentative Labor Deal With SPEEA Workers After Spirit AeroSystems Acquisition 
TikTok Expands AI Age-Detection Technology Across Europe Amid Rising Regulatory Pressure 
Federal Judge Clears Way for Jury Trial in Elon Musk’s Fraud Lawsuit Against OpenAI and Microsoft 
Tesla Revives Dojo Supercomputer Project With AI5 Chip at the Core 
China Halts Shipments of Nvidia H200 AI Chips, Forcing Suppliers to Pause Production 
Syrah Resources and Tesla Extend Deadline on Graphite Supply Dispute to March 
White House Pressures PJM to Act as Data Center Energy Demand Threatens Grid Reliability 
U.S. Moves to Expand Chevron License and Control Venezuelan Oil Sales 
Pop Mart Shares Surge in Hong Kong After First Buyback in Nearly Two Years 
Jamie Dimon Signals Possible Five More Years as JPMorgan CEO Amid Ongoing Succession Speculation 
Proposed Rio Tinto–Glencore Merger Faces China Regulatory Hurdles and Asset Sale Pressure 
TSMC Shares Hit Record High as AI Chip Demand Fuels Strong Q4 Earnings 
Micron to Buy Powerchip Fab for $1.8 Billion, Shares Surge Nearly 10% 
Toyota Industries Buyout Faces Resistance as Elliott Rejects Higher Offer 
SAN DIEGO and TORONTO, April 25, 2017 -- Aptose Biosciences Inc. (NASDAQ:APTO), (TSX:APS), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, today announced that William G. Rice, Chairman, President and Chief Executive Officer, and Gregory K. Chow, Senior Vice President and Chief Financial Officer, will participate at the Bloom Burton & Co Healthcare Investor Conference 2017 on Monday, May 1, 2017 at 2:30 p.m. ET at the Sheraton Centre Toronto Hotel in Toronto, Canada.
Dr. Rice will provide a corporate a corporate overview of the Company’s recent activities and strategic direction.
| Time: | 2:30 p.m. ET | |||||||||
| Date: | Monday, May 1, 2017 | |||||||||
| Location: | Sheraton Centre Toronto Hotel, Toronto, Canada | |||||||||
A live webcast of the Aptose presentation will be accessible by visiting:
http://wsw.com/webcast/bloomburton2/apto
The webcast will be archived shortly after the live event and will be available for 90 days through the Aptose website at www.aptose.com
About Aptose
Aptose Biosciences is a clinical-stage biotechnology company committed to developing personalized therapies addressing unmet medical needs in oncology. Aptose is advancing new therapeutics focused on novel cellular targets on the leading edge of cancer. The company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities. For further information, please visit www.aptose.com.
About the Conference
Bloom Burton & Co. is hosting its sixth annual Healthcare Investor Conference on May 1 and 2, 2017 at the Sheraton Centre Toronto Hotel, Toronto, Canada. We aim to showcase approximately sixty of the premier Canadian healthcare companies to our network of investors, who generally join us from across Canada, the U.S. and Europe. We will have networking sessions, keynote speeches and panel discussions with venture capital, public equity and strategic investors. The event attracts investors who are interested in the latest developments in Canadian healthcare companies. Investors will have the opportunity to obtain corporate updates from presenting companies and participate in our 1-on-1 meeting system with company management.
For further information, please contact: Aptose Biosciences Greg Chow, CFO 647-479-9828 [email protected] SMP Communications Susan Pietropaolo 201-923-2049 [email protected]
